Patent · US Active

Methods of using chimeric receptors to identify autoimmune disease

US8926981B2 · kind B2 · utility

3Cited by
4References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateSep 12, 2012
Grant dateJan 6, 2015
Priority date
Expiry dateSep 12, 2032

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S435/80
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The present invention provides methods and compositions useful in the diagnosis and management of autoimmune diseases. In particular, the present invention provides improved methods and compositions for the diagnosis and management of Graves' disease. The methods of the present invention not only avoids the need for radioactivity and are much simpler, economical, and rapid than methods traditionally used for the diagnosis of Graves' disease, but also improve upon the sensitivity and detection abilities of previous luciferase-based autoantibody detection assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.